ARCHIVES

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

Study Tracks Lifestyle Factors For Cancer Burden In Blacks

October 26, 2001

Clearinghouse Subgroup Okeys Carcinogenesis Testing for Anticancer Drugs

September 8, 1978

IOM Selects Advisors To Defense Department

February 5, 1993

Surgeon General Issues Call To Reduce Skin Cancer Rates

August 1, 2014

Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer

February 25, 2011

In Brief: Robert Day New AACI President, John Potter President Elect: Howard Appointment Near

June 21, 1985